Patent ID: 7160865

Claim:
A method of killing cancer cells in a human, wherein said cancer cells include cancer cells that use steps of the glycolytic pathway to create ATP for energy anaerobically and cancer cells that aerobically generate ATP, said method comprising: administering a cancer chemotherapy protocol selected from the group consisting of: (i) cyclophosphamide, and 5-fluorouracil for breast cancer; (ii) paclitaxel or docetaxel for breast cancer; and (iii) ifosphamide, doxorubicin, and DTIC (dacarbazine) for an osteosarcoma; and administering a glycolytic inhibitor capable of inhibiting at least one step of the glycolytic pathway, wherein said therapy is administered without radiation therapy, and said glycolytic inhibitor is selected from the group consisting of: 2-deoxy-D-glucose; 2-fluoro-D-glucose; and 5-thio-D-glucose.